CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer-Reference-Cited by-同舟云学术

CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer

Published:2023-11 Issue:5 Volume:165 Page:1219-1232
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Xu Yao,Fu Juan,Henderson MacKenzie,Lee Fei,Jurcak Noelle,Henn Anja,Wahl Joachim,Shao Yingkuan,Wang Jianxin,Lyman Melissa,Funes Vanessa,Espinoza Birginia,Zhang Rui,Washington India,Chen Sophia Y.,Zlomke Haley,Wang Junke,Niu Nan,Li Pan,Meng Fengxi,Burns William,Friedrich Matthias,Stienen Sabine,Bailis Julie M.,Zheng Lei^ORCID

Funder

Amgen

Sidney Kimmel Comprehensive Cancer Center

China Scholarship Council

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities;Ho;Nat Rev Clin Oncol,2020

2. Current status of immune checkpoint inhibitors for gastric cancer;Kono;Gastric Cancer,2020

3. Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers;Baxter;Br J Cancer,2021

4. Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia;Wei;Leukemia,2021

5. Abstract #3252: Effector memory T cells make a major contribution to redirected target cell lysis by T cell-engaging BiTE antibody MT110;Kischel;Cancer Res,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD64⁺fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8⁺T cells;Gut;2024-08-26

2. LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma;Cell Death & Differentiation;2024-08-14

3. Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinoma;Journal of Chemotherapy;2024-07-30

4. DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy;Cancer Immunology, Immunotherapy;2024-03-30

5. The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer;Cancers;2023-12-05